Austar Lifesciences Limited
AULSF
$0.07
$0.0651,300.00%
OTC PK
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | -0.48% | 75.58% | -0.86% | 108.04% | -0.31% |
Total Depreciation and Amortization | -0.48% | 12.59% | -0.86% | -1.32% | 0.31% |
Total Amortization of Deferred Charges | -0.50% | 25.33% | -0.84% | -14.16% | 0.31% |
Total Other Non-Cash Items | -0.47% | 245.57% | 0.86% | -106.65% | 0.31% |
Change in Net Operating Assets | -0.48% | -- | -- | -- | -0.31% |
Cash from Operations | -0.48% | 310.36% | -0.86% | 801.19% | 0.27% |
Capital Expenditure | 0.48% | -170.38% | 0.85% | 83.83% | -0.31% |
Sale of Property, Plant, and Equipment | 0.49% | -184.46% | -0.86% | 23,654.05% | 0.00% |
Cash Acquisitions | -0.51% | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -0.48% | 173.07% | -0.85% | -3.63% | 0.31% |
Cash from Investing | 0.49% | -164.88% | -0.86% | 142.68% | -0.31% |
Total Debt Issued | 0.00% | 14.33% | 0.00% | -37.93% | 0.00% |
Total Debt Repaid | 0.00% | -5.69% | 0.00% | -20.83% | 0.00% |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | 0.00% | 12.69% | 0.00% | -25.61% | 0.00% |
Cash from Financing | 0.48% | 18.16% | 0.86% | -187.00% | 0.31% |
Foreign Exchange rate Adjustments | -0.36% | 138.36% | -0.85% | 588.24% | 0.00% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -0.49% | 214.09% | 0.86% | -163.15% | 0.31% |